Walleye Trading’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,500
Closed -$614K 5647
2022
Q3
$614K Buy
+2,500
New +$675K ﹤0.01% 2709
2022
Q1
Sell
-500
Closed -$180K 6140
2021
Q4
$180K Buy
500
+300
+150% +$101K ﹤0.01% 3980
2021
Q3
$65K Sell
200
-2,200
-92% -$745K ﹤0.01% 4555
2021
Q2
$749K Buy
2,400
+1,800
+300% +$552K ﹤0.01% 2455
2021
Q1
$191K Sell
600
-4,400
-88% -$1.41M ﹤0.01% 3680
2020
Q4
$1.62M Buy
5,000
+4,900
+4,900% +$1.36M 0.01% 1565
2020
Q3
$28K Sell
100
-1,500
-94% -$432K ﹤0.01% 3775
2020
Q2
$386K Sell
1,600
-2,600
-62% -$522K ﹤0.01% 2496
2020
Q1
$610K Sell
4,200
-1,500
-26% -$249K ﹤0.01% 1707
2019
Q4
$972K Sell
5,700
-13,400
-70% -$2.48M 0.01% 1834
2019
Q3
$3.4M Buy
19,100
+10,600
+125% +$2.29M 0.03% 681
2019
Q2
$2.21M Sell
8,500
-1,000
-11% -$265K 0.02% 972
2019
Q1
$2.71M Buy
9,500
+3,000
+46% +$997K 0.02% 852
2018
Q4
$2.11M Buy
6,500
+1,000
+18% +$347K 0.02% 1037
2018
Q3
$2.47M Buy
5,500
+3,000
+120% +$1.18M 0.01% 1131
2018
Q2
$1.02M Buy
2,500
+300
+14% +$109K 0.01% 2080
2018
Q1
$640K Buy
+2,200
New +$558K ﹤0.01% 2397
2017
Q3
Sell
-200
Closed -$28 4735
2017
Q2
$28 Sell
200
-2,700
-93% -$363K ﹤0.01% 4050
2017
Q1
$363 Buy
2,900
+2,500
+625% +$290K ﹤0.01% 2520
2016
Q4
$45K Buy
+400
New +$46.3K ﹤0.01% 3699

Other funds holding ABMD

Walleye Trading's ABMD Position: Q3 2022 in Review

Walleye Trading sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 2,925 shares — an estimated $790K sold.

Walleye Trading first reported a position in ABMD in Q3 2015 and held it in 10 quarters. The position peaked at $6.63M in Q3 2018. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • Walleye Trading reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • Walleye Trading sold 2,925 Abiomed Inc shares in Q3 2022, an estimated $790K.
  • Walleye Trading first reported a position in Abiomed Inc in Q3 2015 and held it in 10 quarters.
  • Walleye Trading's Abiomed Inc position peaked at $6.63M in Q3 2018.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.